Yahoo Web Search

Search results

    • Pfizer: An Oversold Pharma Stock in Recovery

      Pfizer: An Oversold Pharma Stock in Recovery

      GuruFocus.com via Yahoo Finance· 7 days ago

      Indeed, from a forecast standpoint, the near future looks bright. While revenue will witness only mild...the next four years, Ebitda is estimated to rise...

    • Is It Too Late to Buy Pfizer Stock?

      Is It Too Late to Buy Pfizer Stock?

      Motley Fool via Yahoo Finance· 5 days ago

      For reference, its trailing-12-month revenue was $54.8 billion. Therefore, if these plans are brought to fruition -- and so far, it looks like they're on...

    • Gateway - Quartz

      Quartz· 22 hours ago

      As of the end of 2022, about a quarter of the population of African countries has been fully vaccinated against covid-19, according to the latest figures shared by Africa ...